University of Texas's Southwestern Medical Center: Anticoagulants Help Moderately Ill COVID-19 Patients
August 20, 2021
August 20, 2021
DALLAS, Texas, Aug. 20 (TNSJou) -- The University of Texas's Southwestern Medical Center issued the following news release:
Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.
Moderately ill COVID-19 patients treated with therapeutic-dose anticoagulation with unfractionated or low molecul . . .
Moderately ill patients hospitalized with COVID-19 have better chances of survival if treated with therapeutic-dose anticoagulation, according to an international study involving 121 sites, including UT Southwestern Medical Center.
Moderately ill COVID-19 patients treated with therapeutic-dose anticoagulation with unfractionated or low molecul . . .